INC makes key Japanese appoitnments
This article was originally published in Scrip
Executive Summary
Clinical research organization INC Research has made three key management appointments in Japan. Hiromi Wakita has been named general manager and clinical director, leading the firm's operations in Japan. He joins INC from previous positions in both pharmaceutical companies and other CRO firms. Hiroshi Uoji has also joined the company as regulatory and safety director for Japan. Finally INC has named Shinichi Sato project director, CNS clinical development in Japan. All three new appointees will be based in the firm's Tokyo Office.